TwitterLinkedInFacebookInstagram

 | 

SearchSearch
United States
    Carrie Eglinton Manner

    Carrie Eglinton Manner

    President & Chief Executive Officer

    Carrie Eglinton Manner was named President and Chief Executive Officer of OraSure Technologies in June 2022 and brings more than 25 years of healthcare leadership and transformation expertise to the Company. Prior to joining OraSure, Ms. Manner was Senior Vice President, Advanced & General Diagnostics Clinical Solutions, at Quest Diagnostics. In that role, she was responsible for bringing innovative diagnostic solutions to market in the areas of women’s health, neurology, oncology, cardiovascular, metabolic, endocrinology, infectious disease, and immunology testing services, as well as drug monitoring and toxicology. She also led Quest’s pharmaceutical services, AmeriPath/Dermpath, and international businesses, as well as their molecular genetics team in pioneering next-generation sequencing innovation. Prior to Quest Diagnostics, Ms. Eglinton Manner served for 20 years in a variety of leadership roles at GE Healthcare, a division of General Electric (GE). A champion for inclusion and diversity, Ms. Eglinton Manner was co-chair for Quest’s African American Employee Business Network and GE’s Women’s Network. Ms. Manner received a B.S. degree in mechanical engineering from University of Notre Dame.

    Ken J. McGrath

    Kenneth J. McGrath

    Chief Financial Officer

    Kenneth J. McGrath was named Chief Financial Officer in August 2022. Prior to joining OraSure, Mr. McGrath spent eight years at Quest Diagnostics, most recently serving as Vice President in Finance, where he led an organization responsible for more than $7 billion in revenue. He helped build Quest’s Advanced Diagnostics business accelerating growth, while improving profitability with expanded capabilities and innovation. His expertise also includes value creation via partnerships and successfully assessing and integrating multiple acquisitions. Mr. McGrath’s finance operating responsibility also spans information technology, R&D and medical functions, as well as commercial regions. Prior to his time at Quest, Mr. McGrath held various leadership positions in finance operating roles at Johnson & Johnson, Inc. He began his career at Ford Motor Company. He received an M.B.A from the University of Michigan and a B.S. from the University of Notre Dame. He is a CFA Charterholder.

    Michele Miller

    Michele Miller

    Senior Vice President, Controller and Chief Accounting Officer

    Michele Miller is the Senior Vice President, Controller and Chief Accounting Officer and is responsible for the Company’s financial accounting and reporting and ensuring compliance with U.S. generally accepted accounting principles (GAAP), establishing appropriate accounting policies and procedures, and for overseeing OraSure’s treasury and tax functions. Prior to taking her current role in January 2022, Ms. Miller started her career at OraSure as the Manager, Financial Reporting and advanced in several positions within the accounting and financial reporting functions to most recently the Company’s Vice President, Finance and Controller. Prior to joining the Company, Ms. Miller served as Manager, Financial Reporting at Knoll, Inc. and as an accountant with Beard Miller Company and Ernst & Young. Ms. Miller received her B.S. in Accounting from Bloomsburg University and is a licensed Certified Public Accountant, a Chartered Global Management Accountant, and a member of the Pennsylvania and American Institutes of Certified Public Accountants.

    Lisa Nibauer

    Lisa Nibauer

    President of Diagnostics

    Lisa Nibauer joined OraSure as Executive Vice President, Business Unit Leader, Diagnostics in May 2020. Prior to joining OraSure, Ms. Nibauer spent eight years at BD Becton Dickinson, Inc. (“BD”), most recently as VP/GM, Global Medication Delivery Solutions. In that role, she had general management responsibility for $1.6 billion in annual revenue and a team of over 300 people globally and was also accountable for the Global Marketing function for the largest business unit in BD. Prior to that, also at BD, Ms. Nibauer held the positions of VP/GM, Global PreAnalytical Systems Business & Global Marketing and Senior Director, Global Blood Collection Acquisition Platform. Prior to joining BD, she held general management, sales and marketing positions with increasing responsibilities at Adlens Beacon Inc., Schering-Plough Consumer Healthcare (Bayer), General Mills, Elf Atochem, and ICI (now part of AstraZeneca, Henkel and AkzoNobel). Ms. Nibauer earned an M.B.A. from UCLA Anderson School of Management and a B.S. in Chemical Engineering from Lehigh University.

    Kathleen Weber

    Kathleen Weber

    President of Molecular Solutions

    Kathleen Weber was named Executive Vice President, Business Unit Leader for Molecular Solutions in January 2019 and promoted to President in January 2022. In this role, she has oversight for the commercial, operational and financial performance of the business unit, which is also known as DNA Genotek and includes our Novosanis and Diversigen wholly owned subsidiaries. Kathy joined OraSure in 2012 as the Senior Vice President and General Manager, Consumer Products. Her role evolved from 2012 to 2018 to also include at various points in time managing the Emerging Disease Portfolio and leading the development of OraSure’s corporate strategy. Prior to joining OraSure, Ms. Weber held several senior commercial leadership positions at Pfizer, Johnson and Johnson and Schering–Plough. Ms. Weber began her career in the financial services industry and held various positions in U.S. and global marketing and operations at Chase Manhattan Bank, now part of JP Morgan Chase. Ms. Weber received a B.S. degree in business administration from Georgetown University and earned an M.B.A. from New York University’s Stern School of Business.

    David Rappaport

    David Rappaport, CFA

    Senior Vice President Corporate Development, Strategy and Integration

    David Rappaport has been the Senior Vice President, Business Development since April 2018. Prior to joining OraSure, Mr. Rappaport served as the Senior Vice President, Healthcare Investment Banking at Raymond James & Associates where he provided investment banking services in the Life Sciences practice group. Prior to his tenure at Raymond James, Mr. Rappaport served as a healthcare investment banker with Inverness Advisors, LLC, Thomas Weisel Partners, and SG Cowen. Mr. Rappaport received a Bachelors of Business Administration in Finance and Economics from the University of Wisconsin and an MBA from Emory University.

    Scott Gleason

    Scott Gleason

    Senior Vice President, Corporate Communications & Investor Relations

    Scott Gleason joined OraSure in May of 2021 serving as the Senior Vice President of Investor Relations and Corporate Communications. Prior to joining OraSure, Mr. Gleason served as the Senior Vice President of Investor Relations and Corporate Strategy for Myriad Genetics, Inc., a leading specialty diagnostic laboratory in the United States focused on genetic testing and precision medicine. At Myriad, he managed the investor relations and corporate communications functions, led the annual strategic planning process, and was a member of the Company's strategic committee. Prior to his tenure with Myriad Genetics, Mr. Gleason was a senior publishing analyst at Stephens, Inc. from 2005 to 2013 covering the life science tools and diagnostics industry. Before joining Stephens, Inc. Mr. Gleason was a United States Air Force aircraft maintenance officer and participated in two wartime deployments. Mr. Gleason received a Bachelor of Science degree from the U.S. Air Force Academy in Colorado Springs, CO.

    Amy Steigerwalt

    Amy Steigerwalt

    Senior Vice President, Human Resources

    Amy Steigerwalt is the Senior Vice President, Human Resources responsible for OraSure Technologies’ global talent strategy, diversity and inclusion, total rewards and employee experience. Ms. Steigerwalt joined OraSure in 2017 with many years of Human Resources leadership experience in various industries. She has an extensive and proven background building successful HR teams focused on talent development, employee engagement and driving best practices in talent acquisition and people management. Prior to joining OraSure Technologies, Ms. Steigerwalt spent three years at Air Products in a Global HR leadership role. Prior to that, she held progressively increasing leadership roles at Knoll from 2006 to 2014, as well as additional Human Resources leadership roles at Estee Lauder and Polo. She holds a B.S. from University of Pittsburgh. Ms. Steigerwalt was recognized in Lehigh Valley’s 40 under 40 as a top leader in the community.

    Zachary Wert

    Zachary Wert

    Senior Vice President, Global Operations

    Zachary Wert joined OraSure as our Senior Vice President of Global Operations in July of 2022. He leads operations for our global enterprise and holds responsibility for all teams across our Diagnostics and Molecular Solutions business units. Mr. Wert is an accomplished senior executive leader with experience in operations, manufacturing, product planning and expansion, and strategic leadership overseeing multi-site, large scale teams and high-volume manufacturing. Prior to joining OraSure, Mr. Wert was Senior Vice President of Reagent Manufacturing for Siemens Healthineers, with direct responsibility for a team of more than 2,000 people, consisting of manufacturing, engineering, quality, planning, procurement, and technical operations, with six global sites producing high-volume diagnostics. Before his work with Siemens, he led operations and product development for ThermoFisher, Bausch + Lomb, Genzyme, and J&J Clinical Diagnostics. Mr. Wert has a bachelor’s degree in chemistry from St. John Fisher College in Rochester, NY, and a master’s of business administration degree from Bryant College in Smithfield, RI.

    Stefano Taucer

    Stefano Taucer

    General Counsel and Corporate Secretary

    Stefano Taucer was named General Counsel and Corporate Secretary in July 2022. He is responsible for overseeing all legal affairs and compliance matters for the entire OraSure family of companies. Mr. Taucer joined OraSure in 2021 and, prior to being appointed as General Counsel, served as Deputy General Counsel, supporting the Molecular Solutions business unit. Previously, he worked as Chief Counsel and Head of Legal for the Canadian R&D operations of a global communications equipment provider, as legal counsel for one of Canada’s largest telecommunications companies, and practiced corporate and securities law at an international law firm. Mr. Taucer holds a law degree from the University of Ottawa and a bachelor's degree in economics from Queen’s University.